Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Damietta, 34517, Egypt
NCT Number: NCT06465784
Objectives: To present the outcomes of retrograde and antegrade ureteroscopic laser lithotripsy in the treatment of proximal ureteral stones ranging in size from 10 to 20 millimeters in diameter.
Patients and methods: From March 2023 to December 2023, 70 patients were included in this prospective randomized double-arm interventional study. Patients were divided into two groups: Group 1: (35 patients) had semi-rigid retrograde ureteroscopic laser lithotripsy and group 2: (35 patients) had semi-rigid antegrade ureteroscopic laser lithotripsy.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
Damietta, 34517, Egypt
The present study was conducted in Al-Azhar University Hospital (Damietta branch), urology department,at the period from March 2023 to December 2023. Seventy patients with symptomatic proximal medium sized ureteric stones were classified in two groups Retrograde Uretroscopic Laser Lithotripsy (group 1) and Antegrade Ureteroscopic Laser Lithotripsy (group 2) .
The preoperative-(patient- and stone-related), intraoperative- and postoperative- related parameters that might influence the perioperative course and short-term clinical outcomes were evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Comparison Between Retrograde and Antegrade Ureteroscopic Laser Lithotripsy for Management of Medium Sized Proximal Ureteral Stones: A Randomized Prospective Study
Time frame: Direct after intervention
number of patients reported complete clearance of stones after intervention
Mahmoud Helmy El saeed Hussein
Other
Comparison Between Retrograde and Antegrade Ureteroscopic Laser Lithotripsy for Management of Medium Sized Proximal Ureteral Stones: A Randomized Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06975488
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Sahiwal, Punjab Province, Pakistan
View Trial DetailsNCT06761378
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cairo, State Or Province, Egypt
View Trial DetailsNCT04759417
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Abu Dhabi, United Arab Emirates
View Trial DetailsNCT05218057
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Sheung Shui, Hong Kong
View Trial Details